209 related articles for article (PubMed ID: 29314745)
1. Stenotrophomonas maltophilia: A marker of lung disease severity.
Berdah L; Taytard J; Leyronnas S; Clement A; Boelle PY; Corvol H
Pediatr Pulmonol; 2018 Apr; 53(4):426-430. PubMed ID: 29314745
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
3. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
[TBL] [Abstract][Full Text] [Related]
5. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
7. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Jahnke N; Waters V
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2014 Apr; (4):CD009249. PubMed ID: 24696136
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2012 May; (5):CD009249. PubMed ID: 22592739
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
Frost F; Nazareth D; Shaw M; Walshaw MJ
J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
[TBL] [Abstract][Full Text] [Related]
13. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.
Marchac V; Equi A; Le Bihan-Benjamin C; Hodson M; Bush A
Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239
[TBL] [Abstract][Full Text] [Related]
15. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
[TBL] [Abstract][Full Text] [Related]
16. Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.
Barsky EE; Williams KA; Priebe GP; Sawicki GS
Pediatr Pulmonol; 2017 Oct; 52(10):1276-1282. PubMed ID: 28815999
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients.
Stanojevic S; Ratjen F; Stephens D; Lu A; Yau Y; Tullis E; Waters V
J Cyst Fibros; 2013 Dec; 12(6):575-83. PubMed ID: 23757360
[TBL] [Abstract][Full Text] [Related]
18. Clinical associations with carriage of pulmonary
Watson L; Priestley L; Chapman SJ; Andersson MI; Jeffery K; Flight WG
J R Coll Physicians Edinb; 2022 Mar; 52(1):14-19. PubMed ID: 36146962
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.
Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V
J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.
Graff GR; Burns JL
Chest; 2002 Jun; 121(6):1754-60. PubMed ID: 12065335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
